Ambarella Inc. (AMBA) News
Filter AMBA News Items
AMBA News Results
|Loading, please wait...|
AMBA News Highlights
- For AMBA, its 30 day story count is now at 18.
- Over the past 15 days, the trend for AMBA's stories per day has been choppy and unclear. It has oscillated between 1 and 9.
- IOT, TALK and AMP are the most mentioned tickers in articles about AMBA.
Latest AMBA News From Around the Web
Below are the latest news stories about AMBARELLA INC that investors may wish to consider to help them evaluate AMBA as an investment opportunity.
After losing 55% in the past year, Ambarella, Inc. (NASDAQ:AMBA) institutional owners must be relieved by the recent gain
To get a sense of who is truly in control of Ambarella, Inc. ( NASDAQ:AMBA ), it is important to understand the...
Investors were bracing for bad news when Ambarella (NASDAQ: AMBA) reported its fiscal second-quarter results, and that's exactly what they received. The computer vision tech specialist reported nearly flat sales through late July and expanding losses thanks to major supply chain challenges. Ambarella's Q2 sales rose 2%, marking a sharp slowdown from the prior quarter's 29% spike.
Not surprisingly, chipmakers such as Ambarella (NASDAQ: AMBA) that were flying high in 2020 and 2021 are down in the dumps this year. In fact, Ambarella stock is more than 70% in 2022. Ambarella released fiscal 2023 second-quarter results (for the three months ending July 31, 2022) on Aug. 30, and investors didn't like what they saw.
ASX vs. AMBA: Which Stock Is the Better Value Option?
In this article, we will take a look at the 10 tech stocks recently downgraded by analysts. If you want to see some other tech stocks receiving updated recommendations from analysts, go directly to Analysts are Downgrading These 5 Tech Stocks. Notable stocks from the tech sector, including HP Inc. (NYSE:HPQ), NVIDIA Corporation (NASDAQ:NVDA) and […]
Ambarella (NASDAQ: AMBA) investors trailed a rapidly declining market this week. The video tech specialist's shares dove 23% through Thursday trading, according to data provided by S&P Global Market Intelligence, even as the wider market fell 2.2%. Ambarella's stock is now down nearly 70% so far in 2022.
Ambarella, Inc. (AMBA)
Q2 2023 Results Conference Call
August 30, 2022 04:30 PM ET
Louis Gerhardy - Corporate Development
Fermi Wang - President and CEO
Brian White - CFO
Conference Call Participants
Matt Ramsay - Cowen
Joseph Moore - Morgan Stanley
Vivek Arya - Bank of America
Gary Mobley - Wells Fargo
Blair Botha - Arete
Ross Seymore - Deutsche Bank
Tore Svanberg - Stifel
Suji Desilva - Roth Capital
Kevin Cassidy - Rosenblatt
Andrew Buscaglia - Berenberg
Richard Shannon - Craig-Hallum
Tristan Gerra - Baird
Good day, and thank you for standing ...
In a report released today, Quinn Bolton from Needham maintained a Buy rating on Ambarella (AMBA - Research Report), with a price target of $110.00. The company's shares closed yesterday at $84.50.Bolton covers the Technology sector, focusing on stocks such as Intel, Semtech, and Ambarella. According to TipRanks, Bolton has an average return of 42.8% and a 68.56% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Ambarella with a $106.36 average price target, a 25.87% upside from current levels. In a report released today, Wells Fargo also maintained a Buy rating on the stock with a $105.
Losers tool, we have compiled a list of Wednesday’s biggest pre-market stock movers, which is as follows: Five Biggest Movers Topping the list on Wednesday is New Jersey-based Bed Bath & Beyond Inc. (NASDAQ:BBBY), which crashed 16.6% at the last check. The slide could have been triggered by the home goods retailer’s proposal to offer, sell, and issue new common shares. However, the terms of the offering are still unknown. Biotechnology company Mirati Therapeutics Inc. (NASDAQ:MRTX) gained 11.2% before the bell following rival Amgen Inc.’s (NASDAQ:AMGN) announcement that its lung cancer drug met the primary end-point in a late-stage trial.
Chipmaker Ambarella edged above Wall Street's targets for its fiscal second quarter but undershot with its outlook.